← All organizations
Drexel University
Academic/HospitalWebsite ↗
Also known as: Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine | Drexel | Drexel College of Medicine | Drexel Coulter Translational Research Partnership Program | Drexel University | Drexel University Center for Weight, Eating and Lifestyle Science | Drexel University College of Medicine | The Center for Pediatric Pharmacotherapy
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1985Last known activity
Jan 1, 2019
Timeline
1890s
- Jan 1, 1891
Drexel University— Founded
Drugs by trial phase (55 distinct, 38 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Aggression
- Anemia
- Anemia, Sickle Cell
- Atrophy
- Autistic Disorder
- Chest Pain
- Communicable Diseases
- Complex Regional Pain Syndromes
- Conduct Disorder
- Disease
- Epilepsy
- Glioma
- Head and Neck Neoplasms
- Hematologic Diseases
- HIV Infections
- Infections
- Inflammation
- Kidney Failure, Chronic
- Leukemia
- Liver Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Osteochondrodysplasias
- Preleukemia
- Reflex Sympathetic Dystrophy
- Renal Insufficiency
- Sickle Cell Trait
- Syndrome
- Thalassemia
- Thrombocytopenia
Recent trials (50)
- NCT03672149CollaboratorPhase 1Jan 1, 2019
- NCT03672149Reponsible party - principal investigatorPhase 1Jan 1, 2019
- NCT03672149Lead sponsorPhase 1Jan 1, 2019
- NCT03103893Lead sponsorPhase 1/Phase 2Jul 12, 2017
- NCT02663596Overall official - principal investigatorPhase 1Jan 1, 2017
- NCT02663596Reponsible party - principal investigatorPhase 1Jan 1, 2017
- NCT02663596Lead sponsorPhase 1Jan 1, 2017
- NCT03134417Lead sponsorN/AFeb 1, 2016
- NCT02257788Lead sponsorPhase 2Sep 1, 2014
- NCT02257788Study chairPhase 2Sep 1, 2014
- NCT01845298Lead sponsorN/AJun 1, 2014
- NCT02438345Lead sponsorPhase 2Nov 1, 2012
- NCT01647633Lead sponsorPhase 1/Phase 2May 31, 2012
- NCT01647633Reponsible party - principal investigatorPhase 1/Phase 2May 31, 2012
- NCT01647633Overall official - principal investigatorPhase 1/Phase 2May 31, 2012
Details
- Founded
- Philadelphia, PA, US Jan 1, 1891
- Last known activity
- Jan 1, 2019